{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:54:04Z","timestamp":1789480444307,"version":"build-2803163510"},"reference-count":26,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Research of Korea Centers for Disease Control and Prevention","award":["2022-ER0603-00#"],"award-info":[{"award-number":["2022-ER0603-00#"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["bmjpo"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Dexamethasone is widely used as a systemic corticosteroid to treat and prevent bronchopulmonary dysplasia (BPD) in preterm infants. We evaluated the current epidemiology of dexamethasone use to prevent BPD and analyse the factors associated with the response to dexamethasone in very low birthweight infants using a nationwide database.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included very low birthweight infants born between January 2013 and December 2020 with a gestational age of 23\u201331 weeks using data from the Korean Neonatal Network registry. Patients were grouped based on their dexamethasone use into \u2018Dex\u2019 or \u2018No Dex\u2019 groups. Clinical variables and data were collected, and the annual trends of dexamethasone use and the proportion of patients who received dexamethasone according to gestational age were analysed. Respiratory outcomes were compared between the groups. Univariate and multivariate analyses were performed to analyse factors associated with the response to dexamethasone in BPD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 11\u2009261 eligible infants, 2313 (20.5%) received dexamethasone, and 1714 (74.1%) of them were diagnosed with moderate-to-severe BPD. The 8-year annual prevalence of dexamethasone use was 17.7\u201322.3%. The \u2018Dex\u2019 group had more moderate-to-severe BPD, more frequent invasive ventilation use at a postmenstrual age of 36 weeks and longer ventilator duration. Birth weight, 5-minute APGAR score, pulmonary hypertension within the first 28 days, surgical treatment of patent ductus arteriosus, medical treatment of patent ductus arteriosus, pathological chorioamnionitis, hydrocortisone or budesonide use, surgical management of necrotising enterocolitis and fungal sepsis were associated with BPD after dexamethasone use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Approximately 20.5% of preterm infants received dexamethasone, and the frequency increased as gestational age decreased. Poor response to dexamethasone was associated with antenatal and postnatal inflammation, low birth weight and early pulmonary hypertension.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjpo-2023-002302","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T06:35:25Z","timestamp":1702967725000},"page":"e002302","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Factors associated with the response to postnatal dexamethasone use in very low birthweight infants: a nationwide cohort study"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7890-6916","authenticated-orcid":false,"given":"Seung Hwan","family":"Baek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Eun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungho","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Gyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joonsik","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungbo","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Seon","family":"Eun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0174-1065","authenticated-orcid":false,"given":"Soon Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joohee","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Jin","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wook","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"2023121822351949000_7.1.e002302.1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41572-019-0127-7","article-title":"Bronchopulmonary dysplasia","volume":"5","author":"Th\u00e9baud","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2023121822351949000_7.1.e002302.2","unstructured":"Network TECoKN . 2021 Korean Neonatal Network Annual Report. Cheongju, Korea: Korea National Institute of Health, 2022."},{"key":"2023121822351949000_7.1.e002302.3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201611-2386ED"},{"key":"2023121822351949000_7.1.e002302.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.23580"},{"key":"2023121822351949000_7.1.e002302.5","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/s41372-021-01083-w","article-title":"Postnatal steroid management in Preterm infants with evolving Bronchopulmonary dysplasia","volume":"41","author":"Htun","year":"2021","journal-title":"J Perinatol"},{"key":"2023121822351949000_7.1.e002302.6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2843"},{"key":"2023121822351949000_7.1.e002302.7","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.163.7.2011060"},{"key":"2023121822351949000_7.1.e002302.8","doi-asserted-by":"crossref","unstructured":"Doyle LW , Cheong JL , Hay S , et al . Early (< 7 days) systemic postnatal corticosteroids for prevention of Bronchopulmonary dysplasia in Preterm infants. Cochrane Database Syst Rev 2021;11:CD001145. doi:10.1002\/14651858.CD001145.pub5","DOI":"10.1002\/14651858.CD001145.pub5"},{"key":"2023121822351949000_7.1.e002302.9","doi-asserted-by":"crossref","unstructured":"Doyle LW , Cheong JL , Hay S , et al . Late (\u2265 7 days) systemic postnatal corticosteroids for prevention of Bronchopulmonary dysplasia in Preterm infants. Cochrane Database Syst Rev 2021;11:CD001145. doi:10.1002\/14651858.CD001145.pub5","DOI":"10.1002\/14651858.CD001145.pub5"},{"key":"2023121822351949000_7.1.e002302.10","doi-asserted-by":"crossref","unstructured":"Cummings JJ , Pramanik AK , COMMITTEE ON FETUS AND NEWBORN . Postnatal corticosteroids to prevent or treat chronic lung disease following Preterm birth. Pediatrics 2022;149. doi:10.1542\/peds.2022-057530","DOI":"10.1542\/peds.2022-057530"},{"key":"2023121822351949000_7.1.e002302.11","doi-asserted-by":"crossref","unstructured":"Ramaswamy VV , Bandyopadhyay T , Nanda D , et al . Assessment of postnatal corticosteroids for the prevention of Bronchopulmonary dysplasia in Preterm neonates: A systematic review and network meta-analysis. JAMA Pediatr 2021;175:e206826. doi:10.1001\/jamapediatrics.2020.6826","DOI":"10.1001\/jamapediatrics.2020.6826"},{"key":"2023121822351949000_7.1.e002302.12","doi-asserted-by":"crossref","unstructured":"Nuytten A , Behal H , Duhamel A , et al . Correction: evidence-based neonatal unit practices and determinants of postnatal corticosteroid-use in Preterm births below 30 weeks GA in Europe. A population-based cohort study. PLOS ONE 2017;12:e0172408. doi:10.1371\/journal.pone.0172408","DOI":"10.1371\/journal.pone.0172408"},{"key":"2023121822351949000_7.1.e002302.13","doi-asserted-by":"publisher","DOI":"10.1159\/000313024"},{"key":"2023121822351949000_7.1.e002302.14","doi-asserted-by":"crossref","unstructured":"Onland W , van de Loo M , Offringa M , et al . Systemic corticosteroid regimens for prevention of Bronchopulmonary dysplasia in Preterm infants. Cochrane Database Syst Rev 2023;3:CD010941. doi:10.1002\/14651858.CD010941.pub3","DOI":"10.1002\/14651858.CD010941.pub3"},{"key":"2023121822351949000_7.1.e002302.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2019.07.062"},{"key":"2023121822351949000_7.1.e002302.16","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/s41372-020-0680-7","article-title":"Hydrocortisone and Bronchopulmonary dysplasia: variables associated with response in premature infants","volume":"40","author":"Clauss","year":"2020","journal-title":"J Perinatol"},{"key":"2023121822351949000_7.1.e002302.17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5385\/nm.2020.27.2.73","article-title":"Factors associated with clinical response to low-dose dexamethasone therapy for Bronchopulmonary dysplasia in very low birth weight infants","volume":"27","author":"Shin","year":"2020","journal-title":"Neonatal Med"},{"key":"2023121822351949000_7.1.e002302.18","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.23235"},{"key":"2023121822351949000_7.1.e002302.19","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-007-8031-4"},{"key":"2023121822351949000_7.1.e002302.20","doi-asserted-by":"crossref","unstructured":"Escoter-Torres L , Caratti G , Mechtidou A , et al . Fighting the fire: mechanisms of inflammatory gene regulation by the glucocorticoid receptor. Front Immunol 2019;10:1859. doi:10.3389\/fimmu.2019.01859","DOI":"10.3389\/fimmu.2019.01859"},{"key":"2023121822351949000_7.1.e002302.21","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.06314"},{"key":"2023121822351949000_7.1.e002302.22","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41390-020-0993-4","article-title":"Pulmonary hypertension in Bronchopulmonary dysplasia","volume":"89","author":"Hansmann","year":"2021","journal-title":"Pediatr Res"},{"key":"2023121822351949000_7.1.e002302.23","doi-asserted-by":"crossref","unstructured":"Hamrick SEG , Sallmon H , Rose AT , et al . Patent Ductus Arteriosus of the Preterm infant. Pediatrics 2020;146:e20201209. doi:10.1542\/peds.2020-1209","DOI":"10.1542\/peds.2020-1209"},{"key":"2023121822351949000_7.1.e002302.24","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-0569"},{"key":"2023121822351949000_7.1.e002302.25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1165\/rcmb.2021-0353PS","article-title":"Postnatal sepsis and Bronchopulmonary dysplasia in premature infants: mechanistic insights into \"new BPD","volume":"66","author":"Salimi","year":"2022","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2023121822351949000_7.1.e002302.26","doi-asserted-by":"crossref","unstructured":"Villamor-Martinez E , \u00c1lvarez-Fuente M , Ghazi AMT , et al . Association of Chorioamnionitis with Bronchopulmonary dysplasia among Preterm infants: A systematic review, meta-analysis, and Metaregression. JAMA Netw Open 2019;2:e1914611. doi:10.1001\/jamanetworkopen.2019.14611","DOI":"10.1001\/jamanetworkopen.2019.14611"}],"container-title":["BMJ Paediatrics Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjpo-2023-002302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T06:35:37Z","timestamp":1702967737000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjpaedsopen.bmj.com\/lookup\/doi\/10.1136\/bmjpo-2023-002302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,18]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/bmjpo-2023-002302"],"URL":"https:\/\/doi.org\/10.1136\/bmjpo-2023-002302","relation":{},"ISSN":["2399-9772"],"issn-type":[{"value":"2399-9772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}